Implantable Devices – PharmaLive

6-Month Use of Implanted Continuous Glucose Monitor Finally Approved

Blood Glucose Monitoring System, Blood Sugar, Business, Coronavirus Disease (COVID-19) Pandemic, FDA, Implantable Devices, Medical Devices, Partnerships, R&D

In concert with partner Senseonics Holdings, Ascensia Diabetes Care announced that the U.S. Food and Drug Administration signed off on the Eversense E3 Continuous Glucose Monitoring System (CGM) System.

Year-End Research Advances Approaches, Both Genetic and Device-Oriented, to Treat Obesity

Calories, CRISPRa, Food, Genes, Implantable Devices, Obesity, Pandemics, R&D, Researchers, Vagus nerves, Weight

A 2017 study found that more than 700 million adults and children worldwide are obese, calling it a “rising pandemic.”

Bayer to phase out Essure birth control device in U.S.

Birth Control, Business, Doctors, FDA, Implantable Devices, Lawsuits, Medical Devices, Therapeutics

Bayer will discontinue the sale of the healthcare company’s birth control product Essure in the United States.